scholarly journals Amb a 1 Unit

2020 ◽  
Author(s):  
Keyword(s):  
Amb A 1

Production of Recombinant Allergens Phl p 1 and Amb a 1 for Detection of Class E Immunoglobulins

2020 ◽  
Vol 46 (6) ◽  
pp. 1221-1228
Author(s):  
O. O. Mikheeva ◽  
M. A. Kostromina ◽  
D. D. Lykoshin ◽  
M. N. Tereshin ◽  
S. K. Zavriev ◽  
...  
Keyword(s):  
Recombinant Allergens ◽  
Amb A 1 ◽  
Class E

Isoallergen Analysis of Pectate Lyases (Amb a 1 and Amb a 2) from Commercial Short Ragweed Pollen

2011 ◽  
Vol 127 (2) ◽  
pp. AB168-AB168 ◽  
Author(s):  
A. Nandy ◽  
S. Augustin ◽  
L. Mitulski ◽  
O. Cromwell
Keyword(s):  
Ragweed Pollen ◽  
Pectate Lyases ◽  
Amb A 1

scholarly journals CLINICAL AND IMMUNOLOGICAL EFFECTIVENESS OF TREATMENT OF RAGWEED POLLINOSIS IN THE SAMARA REGION

2021 ◽  
Vol 23 (4) ◽  
pp. 921-926
Author(s):  
N. N. Zhukova ◽  
M. V. Manzhos ◽  
L. R. Khabibulina ◽  
E. Yu. Syrtsova
Keyword(s):  
Allergic Rhinitis ◽  
Russian Federation ◽  
Allergic Diseases ◽  
Ambrosia Artemisiifolia ◽  
Control Group ◽  
Ambrosia Trifida ◽  
Results Of Treatment ◽  
Amb A 1 ◽  
The Russian Federation ◽  
Time Changes

Allergic rhinitis and bronchial asthma are widespread respiratory allergic diseases. In some territories of the Russian Federation, the dominant cause of pollinosis is ragweed. The aim of the study was to evaluate the clinical and immunological efficacy of ASIT with the allergen Ambrosia artemisiifolia in patients sensitized to Ambrosia trifida in the Samara region. Patients with proven sensitization to Ambrosia trifida was held immunotherapy with Ambrosia artemisiifolia allergoid preseason. After treatment, patients had a decrease in the severity of symptoms of allergic rhinitis according to VAS (p = 0.00001), a decrease in the need for medications (p = 0.0003), as well as the need for corticosteroids against the background of therapy from 34.6% to 0% (p = 0.00001). In 8% of cases, the result of treatment was good, in 69% satisfactory, in 23% unsatisfactory. In the control group, there were no changes in the severity of symptoms (p = 0.858). Also, in the control group, the need for medications remained unchanged and 14.3% of patients continued to use corticosteroids.After ASIT, there was a decrease in the level of IL-4 (p = 0.002), and a decrease in the ratio of IL-4/ IL-10 (p = 0.0063); at the same time, changes in the level of other cytokines (IL-10; IFNγ) were statistically insignificant (p > 0.05). Before treatment, the levels of IL-4/ IL-10 in both groups were comparable, and after treatment, the differences became statistically significant (p = 0.031). We did not get a statistically significant change in the level of IgG4 Amb a 1 or IgG4 Amb trifida. There was no correlation between the level of individual cytokines and the results of treatment. As a result of the conducted ASIT, positive clinical and immunological results were obtained. In most patients, the disease has acquired a controlled course. At the same time, the lack of excellent and low number of good results of ASIT is probably due to the intraspecific allergenic properties of ragweed. 

Amb a 1–immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response☆

2004 ◽  
Vol 113 (2) ◽  
pp. 235-241 ◽  
Author(s):  
Meri K Tulic ◽  
Pierre-Olivier Fiset ◽  
Pota Christodoulopoulos ◽  
Patrice Vaillancourt ◽  
Martin Desrosiers ◽  
...  
Keyword(s):  
Inflammatory Response ◽  
Amb A 1

The immune response in human beings to Amb a 1 linked to ISS DNA

2004 ◽  
Vol 113 (6) ◽  
pp. 1011-1011
Author(s):  
Donald Y.M. Leung ◽  
Harold S. Nelson ◽  
Stanley J. Szefler ◽  
William W. Busse
Keyword(s):  
Immune Response ◽  
Human Beings ◽  
Amb A 1

scholarly journals Chamber and Field Studies demonstrate Differential Amb a 1 Contents in Common Ragweed Depending on CO2Levels

2018 ◽  
Vol 10 (3) ◽  
pp. 278 ◽  
Author(s):  
Young-Jin Choi ◽  
Hae-Rin Oh ◽  
Jae-Won Oh ◽  
Kyu Rang Kim ◽  
Mi-Jin Kim ◽  
...  
Keyword(s):  
Field Studies ◽  
Common Ragweed ◽  
Amb A 1

scholarly journals Amb a 1-immunostimulatory Oligodeoxynucleotide Conjugate Immunotherapy Increases CD4+CD25+ T Cells in the Nasal Mucosa of Subjects with Allergic Rhinitis

2008 ◽  
Vol 57 (4) ◽  
pp. 377-381 ◽  
Author(s):  
Kazuhisa Asai ◽  
Susan C Foley ◽  
Yuki Sumi ◽  
Yasuhiro Yamauchi ◽  
Naoya Takeda ◽  
...  
Keyword(s):  
T Cells ◽  
Allergic Rhinitis ◽  
Nasal Mucosa ◽  
Amb A 1
Sign in / Sign up

Export Citation Format

Share Document